Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India

Open Access

Peer-reviewed

Research Article

V. Ramesh,

Affiliation Dermatology Department, Safdarjung Hospital and Vardhman Mahavir Medical College (VMMC), New Delhi, India
⨯
Ruchi Singh,

Affiliation National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India
⨯
Kumar Avishek,

Affiliation National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India
⨯
Aditya Verma,

Affiliation National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India
⨯
Deepak Kumar Deep,

Affiliation National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India
⨯
Sandeep Verma,

Affiliation National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India
⨯
Poonam Salotra

* E-mail: salotra@vsnl.com

Affiliation National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India
⨯

Reader Comments (0)

Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Leishmaniasis
Is the Subject Area "Leishmaniasis" applicable to this article?

Thanks for your feedback.
Parasitic diseases
Is the Subject Area "Parasitic diseases" applicable to this article?

Thanks for your feedback.
Amastigotes
Is the Subject Area "Amastigotes" applicable to this article?

Thanks for your feedback.
Biopsy
Is the Subject Area "Biopsy" applicable to this article?

Thanks for your feedback.
Kala-azar
Is the Subject Area "Kala-azar" applicable to this article?

Thanks for your feedback.
Promastigotes
Is the Subject Area "Promastigotes" applicable to this article?

Thanks for your feedback.